Abstract: Objective Our previous study showed that tumor tissue-derived formaldehyde at low concentrations plays an important role in bone cancer pain through activating transient receptor potential vanilloid subfamily member 1 (TRPV1).
Introduction
Pain is one of the most common symptoms in cancer patients, 75%-90% of advanced or terminal cancer patients experiencing chronic pain [1] . Malignant bone tumors occur in patients with primary bone cancer, but are more common in distant metastases from other primary cancers, notably those of the breast, lung and prostate [2] .
Formaldehyde is a consistent metabolic product of demethylation (N-, O-, and S-demethylation) [3] . Its concentration is increased in the urine of patients with prostate cancer and bladder cancer and in the expired air from tumor-bearing mice and breast cancer patients [4, 5] who more frequently suffer from bone cancer pain [6] . Formaldehyde is considered a risk factor in the development of chronic bone cancer pain [7] , and our recent research demonstrated for the first time that cancer tissue-derived low concentrations of formaldehyde induce cancer pain [8] .
Transient receptor potential vanilloid subfamily member 1 (TRPV1), a nociceptive receptor in peripheral nerve fibers [9] , plays a pivotal role in the development of cancer pain [10] [11] [12] [13] [14] [15] [16] . Our previous study found that formaldehyde at concentrations as low as 1 mmol/L induces TRPV1 currents in dorsal root ganglion (DRG) neurons [8, 17] . It is well-known that TRPV1 expression increases in periph- and c-Jun N-terminal kinase (JNK), representing three different signaling cascades [18] . It was reported that inhibitors of ERK, p38 and JNK alleviate neuropathic pain [19, 20] , while PKC and PI3K are also involved in the regulation of pain [20, 21] . These protein kinases, once activated, phosphorylate TRPV1, leading to rapid and dynamic changes in pain sensitivity [22] [23] [24] [25] [26] . Exposure of intestinal epithelial cells to low-dose formaldehyde results in MAPK activation [27] , and formaldehyde induces apoptosis through decreased peroxiredoxin 2 via p38 MAPK in lung epithelial cells [28] . So, we set out to determine whether the protein kinase signaling pathway participates in the modulation of TRPV1 expression by formaldehyde in the development of bone cancer pain.
In the present study, a rat model of bone cancer pain and primary cultures of DRG neurons were used to determine whether tumor tissue-derived endogenous formaldehyde regulates TRPV1 expression and if so, the possible underlying signal pathways. Institute and were cultured in RPMI-1640 medium (Hyclone, Logan, UT, USA) containing 10% fetal bovine serum (FBS, heat-inactivated) according to our previous description [8] . Cells in the culture dish were harvested using 0.25% (w/v) trypsin (Hyclone), centrifuged and then washed with phosphate-buffered saline (PBS). The final pellet was re-suspended in PBS, and cells were kept on ice until injection into the tibia. In the heat-killed control group, MRMT-1 cells were diluted to the same final concentrations but boiled in water for 20 min before injection.
In the PBS control group, only PBS was injected.
Establishment of the rat model of bone cancer pain
Female Sprague-Dawley rats weighing 250-300 g were used. Establishment of the bone cancer pain model has been described previously in detail [8, 29] . Briefly, after anesthesia, the rat was placed supine. The left hindlimb was shaved and the skin disinfected with 75% (v/v) ethanol.
A 1-cm rostro-caudal incision was made in the skin over the top half of the tibia. The tibia was carefully exposed with minimal damage to muscles or blood vessels. Using a 23-gauge needle, the bone was pierced 5 mm below the knee joint distal to the epiphyseal growth plate. The needle was inserted at an angle to enable it to be pushed down the 
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Measurement of formaldehyde concentration with high performance liquid chromatography (HPLC)
Formaldehyde concentrations in blood plasma, bone marrow, and tissue homogenates were assessed on day 14 following tumor cell inoculation and in the cultural media of cancer cell lines using HPLC (ESA Biosciences, Chelmsford, MA, USA) based on the previous descriptions with modifications [8, 30] .
Western blot detection of TRPV1 L4 and L5
DRGs or primary cultured DRG neurons were dissoci- Hercules, CA, USA). Membrane protein was extracted following the method described previously [31] . 
RT-PCR detection of TRPV1
Data analysis
Data are expressed as mean ± SEM.
For comparison among groups, ANOVA followed by post hoc analysis (Bonferroni test) was used. P <0.05 was considered as statistically significant.
Results
Formaldehyde concentration increased in tibia marrow and tissues from rats with bone cancer pain
Formaldehyde concentrations by HPLC measurement are shown in further increased at 72 h of incubation in the 100 µmol/L formaldehyde group ( Fig. 2A, B) . Besides, there was no difference in TRPV1 protein expression between the groups treated with 30 and 300 µmol/L formaldehyde and the control group (data not shown).
In addition, TRPV1 mRNA levels detected by RT-PCR showed changes consistent with those of protein expression. In the 100 µmol/L formaldehyde group, TRPV1 mRNA increased at 48 h, and further increased at 72 h (Fig.   2C, D) . Similarly, the expression of TRPV1 mRNA in the groups treated with 30 µmol/L and 300 µmol/L formaldehyde did not differ from that in the control group (data not shown).
Inhibitory effects of MAPK and PI3K inhibitors on
formaldehyde-induced TRPV1 up-regulation in primary cultured DRG neurons After 72-h incubation of cultured DRG neurons with 100 µmol/L formaldehyde alone, TRPV1 protein expression increased significantly (Fig. 3) .
Compared with the formaldehyde-only group, the TRPV1 expression decreased after pre-incubation with the signal transduction pathway inhibitors PD98059, SB203580, SP600125 or LY294002. However, TRPV1 protein expression did not change after addition of BIM (Fig. 3A, B) . 
Discussion
Formaldehyde is a consistent metabolic product of demethylation. Previous studies demonstrated that the formaldehyde level increases in some tissues and the blood of patients with bone cancer pain, but formaldehyde is usually considered as a risk factor (a cause) in the development of cancer [4] [5] [6] [7] . In the present study, formaldehyde concentrations in blood and tissues increased significantly in rats with bone cancer pain. This result is consistent with our previous finding that formaldehyde is increased in the cancer tissues of patients [8] . More importantly, this result in a rat model of cancer pain provides further support for the concept that the elevated formaldehyde is not only a "cause", but also, more interestingly, a "consequence" of the pathogenesis of cancer or bone cancer pain.
TRPV1 is expressed predominantly in peripheral nociceptors and participates in pain sensitization [32] . Our previous study found that cancer tissue-derived endogenous formaldehyde at low pathological concentrations in an acidic environment induces pain responses through TRPV1 activation in rats in vivo [8] .
In the present study, our results showed that TRPV1 protein expression increased in rats with bone cancer pain, and formaldehyde incubation increased TRPV1 expression in cultured DRG neurons.
Here, formaldehyde incubation with cultured DRG neurons mimics the contact of cancer tissue-derived formaldehyde with peripheral afferent nerve fibers innervating the tibia in the rat model of bone cancer pain. These results indicate that formaldehyde induces bone cancer pain not only by activating TRPV1 receptors (as in our previous report [8] ), but also by up-regulating TRPV1 protein expression in peripheral nociceptors.
It is an interesting phenomenon that endogenous formaldehyde at very low concentrations up-regulates TRPV1 expression. To further investigate the mechanisms underlying this, we examined possible signaling transduction pathways involved in the process. The results showed that signaling cascades [33] . TRPV1 expression can result from ERK and p38 signaling [34, 35] . PI3K is another key mediator of central pain sensitization and of inflammatory heat hyperalgesia through TRPV1 sensitization [24, 36] . So, the present study gives preliminary evidence that formaldehyde up-regulates TRPV1 expression through MAPK and PI3K signal pathways, but not the PKC signal pathway. However, more evidence is needed and related interesting questions, for example, interaction or cross-talk among these signaling pathways, are worthy of further investigation.
Previous studies showed that MAPKs, PI3K and their downstream kinases in primary sensory neurons are involved in pain [20, 21] . MAPK and PI3K pathways are usually targets of activating factors in the tumor microenvironment, and increased formaldehyde activates MAPK and PI3K/AKT signal pathways [37] . PI3K in primary DRG sensory neurons is activated by inflammatory agents, and PI3K inhibitors inhibit chemical-and nerve injury-induced pain hypersensitivity, suggesting that PI3K activation contributes to pain [24, 38] .
We note possible differences between the responses of DRG neurons to formaldehyde in two-week-old rat culture and those in adult animals. We chose two-week-old culture because long-term culture of the adult DRG is technically very difficult.
In summary, on the basis of our previous report that 
